Draupnir Bio Employee Directory
Biotechnology ResearchHovedstaden, Denmark11-50 Employees
Draupnir Bio is a Danish biotechnology company focused on expanding targeted protein degradation to extracellular proteins. It is developing oral, small molecule degraders that use the lysosome to remove disease-causing proteins in the extracellular space and at membrane surfaces. This approach aims to address proteins that have been difficult to target with conventional therapies, broadening the scope of TPD beyond intracellular targets. Headquartered in Copenhagen, the company originates as a spin-out from Aarhus University and the Max Planck Society. It has launched a platform called SORTAC to extend targeted protein degradation to extracellular proteins, with evidence of in vitro and in vivo activity against challenging targets. Recent research detailing its approach has been published in Cell Chemical Biology.
1-888-653-2347 
support@leadiq.com 
